We demonstrate a direct causal relationship between treatment with the TXNRD1 inhibitors auranofin and TRi-1 and enhanced in vivo B16F10 tumor progression using the syngeneic lung colonization model. This evidence concerns the gene TXNRD1 and neoplasm.